We have read with interest the article by AlTahan et al1 on a 25 years-old female who was
diagnosed with sensori-motor Guillain-Barre syndrome (GBS) with onset 14 days after a mild …

With interest we read the article by Tekin et al. about a 34yo female who was tested positive
for SARS-CoV-2 in her 37th week of pregnancy [1]. She manifested clinically with mild …

I read with interest the report of Guillain-Barré Syndrome (GBS) in a COVID-19 patient by
Sedagahat et al.[1], in particular the characterization into Acute Motor Sensory Axonal …

A 70-year-old woman, receiving 7.5 mg prednisone as a maintenance therapy for
rheumatoid arthritis (RA), presented with a rapidly, bilateral weakness and tingling sensation …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily
affects the respiratory system. During the global coronavirus disease (COVID-19) pandemic …

Dear Editor, We read with interest the review article by De Sanctis et al. about 18 patients
with Guillain-Barre syndrome (GBS) associated with the SARS-CoV-2 infection (COVID …

Whether COVID-19 can trigger Guillain–Barré syndrome (GBS) is currently controversially
discussed. Recent studies in this and other journals [2–4] indicate an association. However …

Introduction: Acute motor and sensory axonal neuropathy (AMSAN) is a variant of Guillain–
Barré syndrome (GBS), characterized by acute paralysis and the loss of reflexes and …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes
coronavirus disease-2019 (COVID-19), has been a global epidemic in our healthcare …

Objective: Guillain-Barre syndrome (GBS), an autoimmune polyneuropathy characterized by
ascending weakness and characteristic cerebrospinal fluid (CSF) findings, has been …